Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant melanoma and bone resorption.

Y S Lau1, A Sabokbar, H Giele

  • 1Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Oxford OX3 7LD, UK.

British Journal of Cancer
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Sentinel Flap: A Visible Canvas for Organ Transplant Care.

Irish medical journal·2026
Same author

The 2025 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of esophageal and gastroesophageal junction cancer.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Differential cytokine expression in direct and indirect co-culture of islets and mesenchymal stromal cells.

Cytokine·2021
Same author

Effect of minor amounts of β-calcium pyrophosphate and hydroxyapatite on the physico-chemical properties and osteoclastic resorption of β-tricalcium phosphate cylinders.

Bioactive materials·2021
Same author

Safety of major reconstructive surgery during the peak of the COVID-19 pandemic in the United Kingdom and Ireland - multicentre national cohort study.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2021
Same author

The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CT.

Surgical oncology·2020
Same journal

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

British journal of cancer·2026
Same journal

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

British journal of cancer·2026
Same journal

The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

British journal of cancer·2026
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
See all related articles

Tumor-associated macrophages in melanoma metastases can become osteoclasts. Melanoma cells and fibroblasts promote osteoclast formation through RANKL-dependent and independent pathways, contributing to bone destruction.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Osteolysis, or bone breakdown, in skeletal metastases of malignant melanoma is not fully understood.
  • Osteoclasts, responsible for bone resorption, originate from monocyte/macrophage precursors.
  • Tumor-associated macrophages (TAMs) are key immune cells found in the tumor microenvironment.

Purpose of the Study:

  • To investigate the cellular and humoral mechanisms of osteolysis in melanoma skeletal metastases.
  • To determine if TAMs from melanomas can differentiate into osteoclasts.
  • To analyze the role of melanoma cells and fibroblasts in osteoclast formation.

Main Methods:

  • Isolation and culture of TAMs from metastatic melanomas.
  • Culture of TAMs with osteoclastogenic cytokines (RANKL, M-CSF) and inflammatory factors (TNF-α, IL-1α).

Related Experiment Videos

  • Analysis of osteoclast differentiation and resorption.
  • RT-PCR to detect RANKL mRNA in melanoma fibroblasts.
  • Assessment of conditioned media from fibroblasts and melanoma cells on osteoclast formation.

    • Main Results:

    • Melanoma TAMs differentiated into osteoclasts in the presence of RANKL and M-CSF.
    • TAMs also differentiated into osteoclasts via a RANKL-independent pathway when exposed to TNF-α and IL-1α.
    • Melanoma fibroblasts expressed RANKL and induced osteoclast formation, inhibited by OPG.
    • Melanoma cells produced a soluble factor that induced osteoclast differentiation, independent of OPG.

    Conclusions:

    • TAMs within metastatic melanomas can differentiate into bone-resorbing osteoclasts.
    • Melanoma fibroblasts and tumor cells contribute to osteoclastogenesis through both RANKL-dependent and RANKL-independent mechanisms.
    • These findings elucidate key pathways driving osteolysis in melanoma bone metastases.